BWA
42
-2
PBI
62
2
ADT
33
5
CI
66
-2
LMT
40
-5
PCG
74
-6
VRSN
50
-5
NEE
52
-2
DLTR
31
3
MS
50
-8
CMG
50
-6
SE
65
4
ECL
69
-3
VNO
59
3
SYK
57
-2
FLS
46
-7
ADP
70
-3
STZ
54
-4
LEG
29
4
PEP
50
-4
BWA
42
-2
PBI
62
2
ADT
33
5
CI
66
-2
LMT
40
-5
PCG
74
-6
VRSN
50
-5
NEE
52
-2
DLTR
31
3
MS
50
-8
CMG
50
-6
SE
65
4
ECL
69
-3
VNO
59
3
SYK
57
-2
FLS
46
-7
ADP
70
-3
STZ
54
-4
LEG
29
4
PEP
50
-4
Financhill
Back

Nuveen Dow 30sm Dynamic Overwrite Fund Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Sell
32

DIAX
Nuveen Dow 30sm Dynamic Overwrite Fund

Last Price:
14.67
Seasonality Move:
-0.42%
Buy
73

RYTM
Rhythm Pharmaceuticals

Last Price:
54.42
Seasonality Move:
11.04%
Sell
32
Nuveen Dow 30sm Dynamic Overwrite Fund (DIAX) is a Sell

Is Nuveen Dow 30sm Dynamic Overwrite Fund a Buy, Sell or Hold?

  • The current Nuveen Dow 30sm Dynamic Overwrite Fund [DIAX] share price is $14.57. The Score for DIAX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • DIAX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $53.65. The Score for RYTM is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DIAX Stock Price Chart

What is Nuveen Dow 30sm Dynamic Overwrite Fund's stock price today?

  • The Nuveen Dow 30sm Dynamic Overwrite Fund share price today is $14.57
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DIAX is experiencing slight selling pressure.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $53.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

DIAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 54.51 Buy
Chaikin Money Flow: -23139 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.37 - 14.67) Buy
Bollinger Bands (100): (13.91 - 14.45) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.46 Buy
Relative Strength Index (14 RSI): 67.83 Buy
Chaikin Money Flow: -159819 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.64 - 50.28) Buy
Bollinger Bands (100): (39.46 - 48.56) Buy

DIAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.63 Sell
20-day SMA: 14.58 Sell
50-day SMA: 14.31 Buy
200-day SMA: 14.22 Buy
8-day EMA: 14.6 Sell
20-day EMA: 14.53 Buy
50-day EMA: 14.37 Buy
200-day EMA: 14.23 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.55 Buy
20-day SMA: 48.38 Buy
50-day SMA: 47.86 Buy
200-day SMA: 43.39 Buy
8-day EMA: 50.8 Buy
20-day EMA: 49.06 Buy
50-day EMA: 47.17 Buy
200-day EMA: 41.51 Buy

Nuveen Dow 30sm Dynamic Overwrite Fund Earnings Growth & DIAX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.34 per share, and an increase next year of $1.63 per share.

Nuveen Dow 30sm Dynamic Overwrite Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):